Marwan Noel Sabbagh
Direktor/Vorstandsmitglied bei CERVOMED INC.
Profil
Marwan Noel Sabbagh is a professional with current positions as Non-Executive Director at EIP Pharma, Inc. and Director at CervoMed, Inc. He previously served as an Independent Director at Quince Therapeutics, Inc. and held director positions at Cleveland Clinic Lou Ruvo Center For Brain Health and Banner Sun Health Research Institute.
Sabbagh holds a doctorate degree from the University of Arizona and an undergraduate degree from the University of California, Berkeley.
Aktive Positionen von Marwan Noel Sabbagh
| Unternehmen | Position | Beginn |
|---|---|---|
| CERVOMED INC. | Direktor/Vorstandsmitglied | 16.08.2023 |
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 04.11.2021 |
Ehemalige bekannte Positionen von Marwan Noel Sabbagh
| Unternehmen | Position | Ende |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 30.09.2022 |
| Banner Sun Health Research Institute | Direktor/Vorstandsmitglied | - |
| Cleveland Clinic Lou Ruvo Center For Brain Health | Direktor/Vorstandsmitglied | - |
Ausbildung von Marwan Noel Sabbagh
| University of Arizona | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| QUINCE THERAPEUTICS, INC. | Health Technology |
| CERVOMED INC. | Commercial Services |
| Private Unternehmen | 3 |
|---|---|
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Health Technology |
| Cleveland Clinic Lou Ruvo Center For Brain Health | |
| Banner Sun Health Research Institute |
